Skip to main content

Adaptive Biotechnologies Corp (ADPT) research

Adaptive Biotechnologies Corp
ShareXLinkedInReddit
Sector
Life Sciences Tools & Services
Last price
$28.06
As of

Adaptive Biotechnologies Corp (ADPT): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-04.

As of . Source: SEC EDGAR filings for ADPT. Method and limitations.

SHARE THIS CARD

Share the ADPT intelligence card

A branded snapshot of ADPT: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion ADPT intelligence card preview
Post to X
LIVE TERMINAL

See ADPT live in the terminal

Track ADPT's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live ADPT terminal, free

Active signals for ADPT

FREE, NO ACCOUNT

Every signal on ADPT, as it fires

You are seeing 5 of 20 signals recorded on ADPT since 2026-08-03.

The five above landed across 2 days. The other 15 were recorded on 2 other days. 18 of the 20 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in ADPT (2026Q2)

Manager / securityMarket value% portfolioQoQ
VIKING GLOBAL INVESTORS LPCUSIP 00650F109 · 2026Q2$643.4M1.83%,
D. E. Shaw & Co., Inc.CUSIP 00650F109 · 2026Q2$99.2M0.05%,
MILLENNIUM MANAGEMENT LLCCUSIP 00650F109 · 2026Q2$10.8M0.00%,
RENAISSANCE TECHNOLOGIES LLCCUSIP 00650F109 · 2026Q2$6.5M0.01%,
CITADEL ADVISORS LLCCUSIP 00650F109 · 2026Q2$3.9M0.00%,
Bridgewater Associates, LPCUSIP 00650F109 · 2026Q2$860K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, ADPT

ADPT against its peers

ADPT's operating margin of -20.6% ranks in the 35th percentile of 23 Life Sciences Tools & Services sub-industry peers, fiscal periods ending between 2025-10-31 and 2026-06-30.

MetricADPTPeer medianPercentilen
Revenue FY277M USD1.2B USD3725
Gross marginn/a59.1%n/a13
Operating margin-20.6%-3.8%3523
Net margin-21.5%-3.6%3725
Return on equity-27.2%-5.0%2624
P / En/a43.8xn/a11

Peers (25): ABCL, SHC, BRKR, RGEN, FTRE, TXG, AVTR, TEM, TECH, CRL, MEDP, MRVI, MLAB, CTKB, OABI, MTD, DNA, ILMN, WAT, PACB, A, IQV, CDXS, DHR, MXCT. Fiscal periods ending between 2025-10-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (ADPT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more ADPT signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to ADPTand get the insider, 13F, options, and confluence read in one view.

Open the live ADPT terminal, free